Financial Snapshot

Revenue
$30.06M
TTM
Gross Margin
51.88%
TTM
Net Earnings
-$5.297M
TTM
Current Assets
$5.015M
Q3 2021
Current Liabilities
$11.52M
Q3 2021
Current Ratio
43.51%
Q3 2021
Total Assets
$35.96M
Q3 2021
Total Liabilities
$11.97M
Q3 2021
Book Value
$23.99M
Q3 2021
Cash
P/E
-1.182
Nov 25, 2024 EST
Free Cash Flow
$14.58M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2020 2019
Revenue $13.38M $4.463M
YoY Change 199.82%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2020 2019
Revenue $13.38M $4.463M
Cost Of Revenue $6.918M $4.312M
Gross Profit $6.461M $150.5K
Gross Profit Margin 48.29% 3.37%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2020 2019
Selling, General & Admin $5.494M $1.523M
YoY Change 260.63%
% of Gross Profit 85.02% 1012.13%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.644M $436.9K
YoY Change 276.21%
% of Gross Profit 25.44% 290.28%
Operating Expenses $6.807M $1.958M
YoY Change 247.71%
Operating Profit -$345.7K -$1.807M
YoY Change -80.87%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2020 2019
Interest Expense -$90.29K -$263.6K
YoY Change -65.75%
% of Operating Profit
Other Income/Expense, Net $426.9K $66.19K
YoY Change 544.92%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2020 2019
Pretax Income -$659.1K -$2.005M
YoY Change -67.12%
Income Tax $657.6K $0.00
% Of Pretax Income
Net Earnings -$1.317M -$2.005M
YoY Change -34.32%
Net Earnings / Revenue -9.84% -44.92%
Basic Earnings Per Share
Diluted Earnings Per Share -$11.83K -$18.00K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2020 2019
Cash & Short-Term Investments $2.741M $247.9K
YoY Change 1005.59%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $2.527M $1.293M
Prepaid Expenses
Receivables $119.0K $261.4K
Other Receivables $0.00 $0.00
Total Short-Term Assets $5.388M $1.803M
YoY Change 198.86%
Property, Plant & Equipment $4.173M $4.483M
YoY Change -6.92%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.113M $122.6K
YoY Change 807.35%
Total Long-Term Assets $25.74M $12.95M
YoY Change 98.73%
Total Assets $31.12M $14.75M
YoY Change
Accounts Payable $0.00 $1.867M
YoY Change -100.0%
Accrued Expenses $318.6K $269.8K
YoY Change 18.07%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $300.0K $900.0K
YoY Change -66.67%
Total Short-Term Liabilities $3.695M $3.612M
YoY Change 2.29%
Long-Term Debt $7.943M $12.85M
YoY Change -38.19%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $7.943M $12.85M
YoY Change -38.19%
Total Liabilities $11.64M $16.46M
YoY Change -29.31%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2020 2019
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $6.2628 Million

About Mystic Holdings Inc./NV

Mystic Holdings, Inc. operates as a holding company. The company is headquartered in Las Vegas, Nevada. The company went IPO on 2021-07-13. The company provides medical and recreational cannabis cultivation and production, and retail dispensary operations for cannabis and cannabis consumer products. Through its subsidiary, Qualcan, LLC (Qualcan), it wholesales its products including cannabis flowers, edibles and concentrates, under the trademark Qualcan to state-licensed dispensaries utilizing METRC, a state-mandated tracking system. Qualcan has a cannabis cultivation and production facility with the capacity to produce about 600 pounds of sellable cannabis per month. In addition to its wholesale operations, through its wholly owned subsidiaries Picksy, LLC and Picksy Reno, LLC (both of which also do business under the brand name Jade Cannabis Co.), it operates two recreational/medical retail dispensaries (one in Clark County, Las Vegas and one in Reno). The company also has two additional retail dispensary licenses.

Industry: Pharmaceutical Preparations Peers: 9 METERS BIOPHARMA, INC. Aquestive Therapeutics, Inc. Eton Pharmaceuticals, Inc. Enliven Therapeutics, Inc. JOHNSON & JOHNSON OPIANT PHARMACEUTICALS, INC. Longboard Pharmaceuticals, Inc. Medicine Man Technologies, Inc. Odonate Therapeutics, Inc.